The Business Development Representative (BDR) will be the face of HeartFlow within a specific geographic region. The BDR will work with customers to ensure that they are extremely successful with HeartFlow’s non-invasive cardiovascular diagnostic technology. It is your responsibility to drive adoption through the network of referring physicians. You will work with your accounts proactively to support, educate, and provide solutions to build high customer satisfaction. This is a customer- facing role with a primary focus on spending time with customers including Cardiologists, Primary Care Physicians, Nurse Practitioners, and beyond. Expect approximately 20-25% travel from a home office.
The HeartFlow analysis is a first-of-its-kind noninvasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD).
- Will work with key strategic HeartFlow accounts to drive growth and adoption of a cCTA and FFRct clinical pathway. In these accounts, the BDR will develop and execute business development plans working closely with the account’s key stakeholders
- Facilitate cross-functional collaboration throughout the organization. Tools for program development could include key deployment of HeartFlow internal leadership and physician mentors, organizing and staffing of dinner programs, VIP Visits, organizing HeartFlow CT Pathway road-shows, referring physician office meetings, etc. This role will work closely with the other HeartFlow team members to include respective DSM, Marketing, Market Access, CT Apps, Product Development and Clinical
- Increase HeartFlow usage within the designated key strategic HeartFlow account by: 1) Maintaining and building relationships with referring physicians and other key clinical stakeholders 2) Educating customers on HeartFlow’s value proposition by giving presentations / having discussions with referring MDs 3) Promoting / championing HeartFlow and building advocac
- Production/Success/Achievement of the Business Development Representative will be evaluated and based on performance in active/targeted accounts(metrics): 1) Meet / exceed quota for the strategic HeartFlow account (within existing customer locations) 2) cCTA growth (conversion of non-invasive tests) and FFRct penetration / case growth over baseline (% and $) in assigned accounts.